Foghorn Therapeutics, Inc

Foghorn Therapeutics, Inc

Foghorn Therapeutics, Inc

Based in Cambridge, Massachusetts, Foghorn Therapeutics uses its proprietary Gene Traffic Control product platform to discover and develop drugs based on novel insights into the chromatin regulatory system, which directs gene expression in cells.
Founded
2016
Raised
$50M
Follow us
Alexa global traffic share